Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes—a retrospective study from a large urban cohort in Johannesburg, South Africa
- 20 April 2012
- journal article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 18 (3) , 162-171
Abstract
Peripheral neuropathy (PN) is associated with advanced HIV disease and may be a complication of antiretroviral therapy (ART) or anti-tuberculosis (TB) drugs, specifically isoniazid (INH). The effect of non-ART-drug-related PN on treatment outcomes is yet to be determined. We analysed prospectively collected cohort data for HIV-infected ART-naive adults initiating ART at the Themba Lethu Clinic, Johannesburg, South Africa from June 2004 to June 2009. Patients who presented with signs and symptoms of numbness or dysesthesia prior to initiation of ART were defined as having PN. Cox proportional hazard models were used to estimate the effect of PN alone (HIV-related PN) or PN with a history of INH use (TB-related PN) on mortality, lost to follow-up (LTFU), persistent and recurrent PN by 12 months of follow-up. Of the 9,399 patients initiating ART, 3.9 % had HIV-related PN while a further 1.8 % had TB-related PN. Patients with PN did not have a significantly higher risk of mortality compared to those without PN (hazard ratio (HR) 1.17 95 % CI 0.92-1.49). Patients with TB-related PN were less likely to be LTFU by 12 months (HR 0.65 95 % CI 0.44-0.97) compared to those without PN. Patients with HIV-related PN were at increased risk of persistent PN at 3 months post-ART initiation. Patients with HIV-related PN had a similar risk of recurrent PN compared to those with TB-related PN (HR 1.28 95 % CI 0.72-2.27). We demonstrate that patients with PN at initiation of ART present with advanced HIV disease. Completion of TB treatment may reduce the risk of persistent PN in patients with TB-related PN. Use of HIV drugs, even neurotoxic ones, may overall limit neuropathy.Keywords
This publication has 26 references indexed in Scilit:
- A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjectsBMC Infectious Diseases, 2011
- Peripheral neuropathy in HIV: prevalence and risk factorsAIDS, 2011
- Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian populationBMC Public Health, 2010
- Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South AfricaAIDS, 2010
- Effect of pulmonary tuberculosis on mortality in patients receiving HAARTAIDS, 2009
- Hepatitis C virus seropositivity in a South African Cohort of HIV co‐infected, ARV naïve patients is associated with renal insufficiency and increased mortalityJournal of Medical Virology, 2008
- Markers of immune activation and viral load in HIV-associated sensory neuropathyNeurology, 2005
- HIV and hepatitis C coinfection within the CAESAR studyHIV Medicine, 2004
- The relationship of disease severity, health beliefs and medication adherence among HIV patientsAIDS Care, 2000
- HIV-Associated Peripheral NeuropathyDrugs, 2000